Received Jan 19, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 2 | 947932 | IM / RA |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 3 | Z002397 | IM / RA |
Patient presented to office 12/19/25 for his 2nd Hepliav-B dose and was inadvertently given the HPV vaccine instead. HPV vaccine was too early for 3rd dose. Provider and patient were informed of incident. Patient scheduled to return on 3/13/26 to repeat 3rd dose. Provider approved of patient receiving Heplisav-B 12/19/25 as scheduled.
None
GERD, Allergic rhinitis
Allegra, Flonase, omeprazole
Amoxicillin/Penicillin, Compazine
None